期刊文献+

淋巴结清扫个数对T_(1a)N_0期非小细胞肺癌预后的影响 被引量:3

Effect of lymph node dissection on prognosis of stage T_(1a)N_0 non-small cell lung cancer
下载PDF
导出
摘要 目的探讨淋巴结清扫个数对T_(1a)N_0期非小细胞肺癌预后的影响。方法提取美国国家癌症研究所开发的监测、流行病学和结果(SEER)数据库1998至2011年接受手术治疗的T_(1a)N_0期(肿瘤直径≤10mm且无淋巴结转移)非小细胞肺癌患者的临床资料。按照手术淋巴结清扫个数分为3组,即A(0个)、B(1~5个)和C(≥6个)组。随访截止时间为2011年,利用Kaplan-Meier法和Cox比例风险模型分析淋巴结清扫个数对非小细胞肺癌患者预后的影响。结果不同年龄、病理类型、手术范围、诊断年份的非小细胞肺癌患者淋巴结清扫个数比较,差异均有统计学意义(均P<0.05)。A、B、C组患者3年生存率分别为87.1%、89.4%和92.2%,5年生存率分别为77.3%、83.9%和86.7%,10年生存率分别为66.5%、73.1%和77.8%。C组患者预后优于A组(P<0.05);而B与A、C组预后比较,差异均无统计学意义(均P>0.05)。经Cox比例风险模型分析,性别、分化程度是影响T_(1a)N_0期非小细胞肺癌患者预后的独立相关因素(均P<0.05);进一步作亚组分析,发现女性亚组中,A、B、C组患者预后比较,差异无统计学意义(P>0.05);而男性亚组中,C组患者明显优于A、B组(均P<0.05)。结论对于T_(1a)N_0期非小细胞肺癌患者,淋巴结清扫可改善男性患者的预后,但对女性患者意义不大。 Objective To investigate the effect of lymph node dissection on the prognosis of T1aN0 non-small cell lung cancer(NSCLC). Methods Clinical data of patients with T1aN0 NSCLC receiving surgical treatment from 1998 to 2011 were extracted from the Monitoring, Epidemiology and Outcomes(SEER) database developed by the National Cancer Institute.According to the number of lymph node dissected, patients were divided into 3 groups: A(0), B(1-5) and C(≥6) groups. The patients were followed up until 2011. The Kaplan-Meier method and the Cox proportional hazard model were used to analyze the effect of lymph node dissection on the prognosis of NSCLC patients. Results Total 973 patients with stage T1aN0 non-small cell lung cancer were included in the analysis, including 397 males and 576 females aged 23-80 years. There were significant differences in number of lymph node dissected among patients with different ages, pathological types, surgical scope and diagnosis years(P〈0.05). The 3-year survival rates of patients in groups A, B, and C were 87.1%, 89.4%, and 92.2%, respectively. The 5-year survival rates were 77.3%, 83.9%, and 86.7%, respectively. The 10-year survival rates were 66.5%, 73.1%, and 77.8%,respectively. The prognosis of patients in group C was better than that in group A(P〈0.05). There was no significant difference in the prognosis between groups B and A, between groups B and C(P〈0.05). Cox proportional hazards model showed that gender and degree of differentiation were independent factors affecting the prognosis of patients(P〈0.05). Further stratification by gender showed that the prognosis for male patients in group C was significantly better than that in groups B and C(both P〈0.05), but not for female patients(P〈0.05). Conclusion In patients with T1aN0 non-small cell lung cancer, lymph node dissection can improve the prognosis of male patients, but it is of little significance for female patients.
作者 姜婷 温广华 董科 傅健飞 赵天涯 张倩倩 JIANG Ting;WEN Guanghua;DONG Ke(Department of Nuclear Medicine,Jinhua Central Hospital,Jinhua 321000,China)
出处 《浙江医学》 CAS 2018年第18期2028-2030,2037,2193,共4页 Zhejiang Medical Journal
关键词 非小细胞癌 淋巴结清扫 手术切除 Non-small cell lung cancer Lymph node dissection Surgical resection
  • 相关文献

参考文献3

二级参考文献37

  • 1Gajra A, Newman N, Gamble GP, et al. Effect of number of lymph nodes sampled on outcome in patients with stage Ⅰ non-small-cell lung cancer. J Clin Oncol,2003,21:1029-1034.
  • 2Wu Y ,Huang ZF,Wang SY ,et al. A randomized trial of systematic nodal dissection in resectable non-small cell lung cancer. Lung Cancer,2002,36 : 1-6.
  • 3Ludwig MS, Goodman M, Miller DL, et al. Postoperative survival and the number of lymph nodes sampled during resection of nodenegative non-small cell lung cancer. Chest ,2005,121 : 1545-1550.
  • 4Goldstraw P. Report on the international workshop on intrathoracic staging. London, October 1996. Lung Cancer, 1997,18 : 107-111.
  • 5Wu J,Ohta Y,Minato H, et al. Nodal occuh metastasis in patients with peripheral lung adenocarcinoma of 2.0 cm or less in diameter. Ann Thorac Surg,2001,71:1772-1777.
  • 6Gu CD, Osaki T, Oyama T, et al. Detection of micrometastatic tumor cells in pN0 lymph nodes of patients with completely resected nonsmall cell lung cancer: impact on recurrence and survival. Ann Surg,2002,235 : 133-139.
  • 7Okada M, Sakamoto T, Yuki T, et al. Selective mediastinal lymphadenectomy for clinico-surgical stage Ⅰ non-small cell lung cancer. Ann Thorac Surg,2006,81 : 1028-1032.
  • 8Takizawa T,Terashima M, Koike T, et al. Mediastinal lymph node metastasis in patients with clinical stage Ⅰ peripheral non-small- cell lung cancer. J Thorac Cardiovasc Surg, 1997,113:248-252.
  • 9Kelly RF, Tran T, Holmstrom A, et al. Accuracy and costeffectiveness of tSF-2-fluoro-deoxy-D-glucose-positron emission tomography scan in potentially resectable non-small cell lung cancer. Chest ,2004, 125 : 1413-1423.
  • 10Allen MS, Darling GE, Pechet T, et al. Morbidity and mortality of major pulmonary resections in patients with early-stage lung cancer: initial results of the randomized, prospective ACOSOG Z0030 trial. Ann Thorac Surg,2006 ,81:1013-1019.

共引文献11

同被引文献37

引证文献3

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部